Image credit: Magnific
Indian healthcare company Romsons Group has completed a strategic private equity transaction with Temasek, a Singapore-based global investment company.
Under the transaction, Temasek has joined Romsons as a long-term strategic partner through a minority investment, bringing together Romsons’ established healthcare platform and operating capabilities in India with Temasek’s global experience and long-term investment perspective.
Romsons described the transaction as “a significant milestone” in the company’s 70-year journey, providing a foundation for its continued expansion in India and international markets.
The partnership with Temasek goes beyond a capital investment and is intended to support Romsons’ growth ambitions and strengthen its capabilities.
Kishore Narain Khanna, managing director, Romsons Group, said, “We have built Romsons on a strong foundation in the Indian healthcare market, and this partnership gives us an opportunity to take that foundation forward with greater scale, capabilities and a global perspective.”
He added that the company’s immediate focus will remain on strengthening its core business and investing across products, manufacturing, technology and people, while continuing to build a trusted and sustainable healthcare enterprise.
Over the past seven decades, Romsons has established a presence in medical devices and hygiene products, supported by its understanding of the Indian healthcare market and an expanding portfolio of products and capabilities.
As healthcare delivery and medical technology continue to evolve, the company sees opportunities to expand its footprint, strengthen its product portfolio and build a globally relevant healthcare enterprise from India.
Temasek’s global experience, institutional capabilities and long-term perspective are expected to complement Romsons’ operating strengths and market understanding. As part of the partnership, Romsons and Temasek will also evaluate strategic partnerships and acquisitions in India and overseas that align with the company’s objectives.
Sanjeev Kharbanda, Group CFO, Romsons Group, said, “Temasek’s investment marks an important step in Romsons’ institutional evolution and provides a strong foundation for the company’s future.”
“As we scale the business, our focus will remain on disciplined capital allocation, strengthening financial and governance processes, and making strategic investments across manufacturing, technology, products and people. We believe this partnership will enhance our ability to pursue opportunities responsibly while maintaining a strong and sustainable financial foundation,” he added.
As Romsons enters this next phase of its growth, the company said it will continue to place strong emphasis on governance, institutional processes and disciplined execution. Strengthening these areas will be important as it scales operations, builds organisational capabilities and responds to emerging opportunities in the medical devices and healthcare sectors.
Looking ahead, Romsons remains focused on building a sustainable healthcare business with the capabilities, scale and institutional strength needed to participate in the sector’s evolution. The company also plans to evaluate the possibility of accessing public markets at an appropriate time, subject to its business trajectory and prevailing market conditions.
